Follow-The-Filings

Security · featured owners

GKOS Glaukos Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.5%
  • $39M
  • 2 new 1 exit

GKOS (Glaukos Corp.) is held in 2 featured 13F books as of 2026 Q2. Ben Jacobs - Anomaly Capital Management is the largest tracked holder by portfolio weight (1.5%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.5% (Ben Jacobs - Anomaly Capital Management) · not free-float ownership

  1. Ben Jacobs New 1.5%
  2. Polen Capital Management New 0.01%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Ben Jacobs - Anomaly Capital Management 2026 Q2 1.5% New 1.5% 275,995 $39M History
Polen Capital Management 2026 Q2 0.01% New 0.01% 4,818 $673K History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 2,600 $280K History

2 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 5 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 25, 2026 Filing Doc
4 Period Sep 16, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 11, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Jul 31, 2026 Filing Doc
4 Period Jul 16, 2026 Filing Doc
4 Period Jul 9, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jul 6, 2026 Filing Doc
4 Period Jun 25, 2026 · 3 forms Filing Doc
4/A Period May 28, 2026 · 7 forms Filing Doc
4 Period Jun 16, 2026 Filing Doc
4 Period May 28, 2026 · 3 forms Filing Doc

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $314.71M $383.48M $507.44M
Gross profit $239.14M $289.45M $282.76M
Gross margin * 76.0% 75.5% 55.7%
Net income -$134.66M -$146.37M -$187.69M
Net margin * -42.8% -38.2% -37.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $395.46M $449.79M $474.98M
Total non-current assets * $544.95M $524.96M $418.5M
Total assets $940.41M $974.76M $893.49M
Total current liabilities $74.01M $75.12M $101.28M
Total non-current liabilities * $404.63M $132.7M $136.06M
Total equity $461.77M $766.93M $656.16M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$57.76M -$61.32M -$14.79M
Cash from investing $14.1M $47.83M -$77.61M
Cash from financing $15.04M $91.54M $11.89M
Net change in cash -$27.28M $75.04M -$79.71M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders